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Osteopontin expression correlates with adhesive and metastatic
potential in metastasis-inducing DNA-transfected rat mammary
cell lines
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A metastatic phenotype can be induced in benign rat mammary cells (Rama 37 cells) by transfecting them with metastasis-inducing
DNAs (Met-DNAs). Stable transfection of Met-DNAs increases the level of the metastasis-associated protein, osteopontin.
Randomly picked clonal cell lines have been established from the pool of Rama 37 cells transfected with one metastasis-inducing
DNA, C9-Met-DNA. In these cell lines, moderate correlation is observed between the copy number of C9-Met-DNA and their
metastatic potential (linear regression coefficient, R
2¼0.48). A very close correlation is observed between the cell lines’ metastatic
potential in vivo and the osteopontin mRNA levels in vitro (R
2¼0.74), but not with another metastasis-associated protein in this
system, S100A4 (R
2¼0.21). A close correlation is also observed between osteopontin mRNA levels and the adhesive potential
(R
2¼0.91) of the cells, but not with their growth rate in vitro (R
2¼0.03). These observations support the previous suggestion that
osteopontin is the direct effector of C9-Met-DNA and that the presence of C9-Met-DNA is necessary, if not sufficient, for the
induction of metastasis in vivo in this system. Additionally, these results suggest that Rama 37 cells with increased osteopontin mRNA
levels become metastatic not through an increased growth rate, but through an increase in cellular adhesiveness.
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Breast cancer is one of the leading causes of death from cancer in
women (Pisani et al, 1999a,b). More specifically, it is the
metastasis of the primary breast tumour to distant sites in the
body that causes the majority of deaths attributed to breast cancer.
Metastasis of breast tumours is frequently life threatening with
only 20% of patients diagnosed with metastatic disease surviving
after 5 years (American Cancer Society, 1998). One assay for genes
that can induce metastasis in breast cells uses the karyotypically
stable rat mammary epithelial cell line Rama 37, which is derived
from a benign 1, 12 dimethyl benz(a) anthracene-induced
mammary tumour as a recipient (Dunnington et al, 1983). The
Rama 37 cell line yields nonmetastasising tumours when injected
into the mammary fat pads of syngeneic rats. However, when this
cell line is transfected with certain genes, the primary tumours
metastasise to the lungs and lymph nodes. Transfected genes that
can induce metastasis in this system include those for S100A4
(Davies et al, 1993), osteopontin (Oates et al, 1996) and Cutaneous
Fatty Acid Binding Protein (Jing et al, 2000), but not conventional
growth-promoting genes such as Ha-ras (Davies et al, 1994) and
FGF2 (Davies et al, 1996). The products of those genes, which can
induce a metastatic phenotype when transfected into Rama 37
cells, have also been shown to occur at higher levels in malignant
than in benign, human breast tumours (Jing et al, 2000; Platt-
Higgins et al, 2000; Rudland et al, 2002) and for S100A4 and
osteopontin are associated with premature death of patients from
metastatic breast disease (Platt-Higgins et al, 2000; Rudland et al,
2002).
In an attempt to identify further regions of the genome that may
be involved in metastasis, restriction enzyme-fragmented DNA of
the malignant cell line Ca2-83 from a metastatic breast cancer was
transfected into the Rama 37 cell line and tested for metastatic
capacity in the animal model system (Davies et al, 1994).
Six fragments of metastasis-inducing DNA (Met-DNA) were
subsequently identified which could induce a metastatic phenotype
when transfected into the Rama 37 cell line. All Met-DNAs
separately induced the expression of osteopontin (Chen et al,
1997), in at least one case (C9-Met-DNA) by the removal
of an inhibitory transcription factor Tcf-4 from the osteopontin
promoter (El-Tanani et al, 2001). Although the six Met-DNAs
produced different elevated levels of osteopontin mRNA in
the resultant pools of transfectants, there was no obvious
correlation between these levels and the number of animals
bearing metastases, suggesting that osteopontin may be acting
indirectly (Chen et al, 1997). Moreover, although the mechanism
by which osteopontin overexpression induces a metastatic
phenotype in the Rama 37 system is unknown, there is evidence
to link osteopontin with many of the cellular events that are
involved in metastasis, such as avoidance of the immune system,
cellular migration (Liaw et al, 1995; Singh et al, 1995; Tuck et al,
2000), invasion (Tuck, 1999) and adhesion (Liaw et al, 1994; Barry
et al, 2000).
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the original pool of C9-Met-DNA-transfected Rama 37 cells and the
molecular and cellular characteristics of each of these clonal cell
lines have been investigated. The results now show that
osteopontin is the direct effector of metastasis in this system.
Additionally, a direct correlation between osteopontin mRNA
levels, metastatic potential and cellular adhesion has been shown
for the first time, leading to the suggestion that osteopontin
induces metastasis in Rama 37 cells, at least in part, by a process
reflected in their increased adhesiveness on plastic substrata and
not by providing any growth advantage over the untransfected
Rama 37 cells.
MATERIALS AND METHODS
Cell culture
All cell lines were maintained as described previously (Dunnington
et al, 1983) in a humidified atmosphere of 90% (vv
 1) air and 10%
(vv
 1)C O 2 in routine medium (RM) (Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco BRL, Paisely, Scotland) with 5% (vv
 1)
foetal calf serum (FCS) (Sigma, Dorset, UK), 50ngml
 1 insulin and
hydrocortisone). The control cell line Rama 800 was obtained from
a transplantable rat mammary tumour (Jamieson and Rudland,
1990). Passaging of cells at a 1:8 dilution was carried out at 70–
80% confluence using trypsin in EDTA, 0.05% (vv
 1).
Establishment and testing of clonal cell lines
Clonal cell lines were established from the pool of Rama 37 cells
transfected with C9-Met-DNA by plating approximately 10000
cells in 9cm diameter dishes. After 1 week, colonies derived from
single cells were harvested by placing over the colony a 4mm
diameter disc of Whatman filter paper soaked in trypsin 0.05%
(vv
 1) in EDTA and incubating for 10min at 371C. The discs of
paper with the cells attached were subsequently placed in one well
of a 24-well plate in cloning medium (CM) (45% (vv
 1) DMEM
(Gibco BRL), 10% (vv
 1) FCS (Sigma), 45% (vv
 1) RPMI (Gibco
BRL), 50ngml
 1 hydrocortisone and insulin). When there were
sufficient cells to be plated into 4, 9cm diameter Petri dishes, they
were transferred and maintained in RM. Plating efficiency was
determined by plating the cell lines at a known density (20000–
30000 cells per dish) in conditioned media generated from the RM
of cells that had been growing exponentially in a 9cm diameter
plate for 3 days. After plating and incubation for 15min at 371Ct o
allow cells to adhere to the plate, the cells were removed from the
plate with trypsin/EDTA solution and counted in a Coulter
counter. Plating efficiency was calculated as the percentage of
cells that had adhered after 15min. Three independent experi-
ments were carried out in triplicate and error bars represent the
standard deviation of the three separate experiments. Cell growth
assays were carried out by plating a known density of cells (5–
10000 per well) in 24-well plates. Every day for 6 days, cells in a set
of triplicate wells were completely removed by trypsinisation and
counted in a Coulter counter. Growth curves were plotted and the
gradients of the curves were obtained using linear regression
analysis. Growth rates were subsequently represented as a
percentage of that for the Rama 37 cell line. Experiments were
carried out three times in triplicate and the error bars represent
the standard deviation of three separate experiments.
Assay for metastasis
Metastasis assays were carried out as described previously
(Dunnington et al, 1983). Cells (2 10
6) to be assayed, suspended
in 0.2ml phosphate-buffered saline (PBS), were injected into the
right inguinal mammary fat pads of approximately 20 female Furth
Wistar rats of 6–10 weeks of age. Animals were observed every 3
days and killed after 3 months. The primary tumour and lungs of
each animal were then fixed in Methacarn (60% (vv
 1) methanol,
10% (vv
 1) acetic acid and 30% (vv
 1) Inhibisol) and embedded
in paraffin wax. Sections of 5mm were then cut and stained with
haematoxylin and eosin. Analysis of the stained lung sections
allowed individual animals to be scored positive or negative for
lung metastasis by two observers. Metastatic potential of the cell
lines was expressed as the percentage of tumour-bearing animals
exhibiting lung metastases. Animals were maintained under UK
Home Office Project Licence no. 40/1515 to Professor PS Rudland
in accordance with the guidelines set down by the United Kingdom
Coordinating Committee for Cancer Research.
Northern and Southern blotting
DNA and RNA from the cell lines were isolated by ultracentrifuga-
tion through caesium chloride gradients of guanidine isothiocya-
nate cell extracts, as described previously (Coombs et al, 1990;
Anandappa et al, 1994). Southern transfer was carried out as
described in Sambrook et al (1989). Ten mgo fEcoR1-digested
genomic DNA was resolved on a 0.8% (wv
 1) agarose gel and
blotted overnight on to Hybond-N membrane (Amersham
Pharmacia, Buckinghamshire, UK) in 20 SSC. DNA was fixed
on the membrane by exposure to UV light. RNA for Northern
blotting was resolved on a 0.8% (wv
 1) formaldehyde agarose gel
and blotted onto Hybond-N membrane (Amersham Pharmacia) in
10 SSC. RNA was fixed onto the membrane by exposure to UV
light. Probes radioactively labelled with a-[
32P]dCTP (ICN,
Hampshire, UK) (specific activity 41 10
8d.p.mmg
 1 DNA) were
generated for Northern and Southern blotting using a random
primed labelling kit (Roche Molecular Chemicals, Hertfordshire,
UK). The 1500bp osteopontin cDNA probe was obtained by
digestion of the pBKCMV-OPN plasmid (Oates et al, 1996) with
restriction enzymes Xba1 and Kpn1. The 300bp S100A4 cDNA was
a PCR product of full-length rat S100A4 cDNA obtained from Dr I
Hickson (University of Liverpool, UK). The 1000bp C9-Met-DNA
probe was obtained by digestion of the pKS-C9-Met-DNA plasmid
(Chen et al, 1997) with HindIII. Hybridisation for Northern and
Southern blots was carried out at 421C in formamide buffer
(5 SSC, 50% (vv
 1) formamide, 1 Denhardt’s solution (Sam-
brook et al, 1989), 5% (wv
 1) dextran sulphate and 3mgml
 1
sonicated salmon sperm DNA). After washing the membranes
consecutively with: (1) 2 SSC, 0.1% (wv
 1) sodium dodecyl
sulphate (SDS); (2) 0.2 SSC, 0.1% (wv
 1) SDS; and (3) 0.1 SSC,
0.1% (wv
 1) SDS, hybridisation signals were visualised by
exposing the wrapped membrane to autoradiographic film for
6–72h with an intensifying screen. Hybridisation signals were
quantified using a Model XL 77CECCD video camera and
MacIntosh IMAGE and PHOTO computer packages (NIH,
Bethesda, MD, USA). C9-Met-DNA copy number was determined
by comparing the intensity of C9-Met-DNA hybridised bands from
the Rama cells to plasmid copy number controls on the same
membrane. Although the amount of plasmid DNA and cellular
DNA loaded onto the gel was different, comparison of relative
intensities of hybridised bands of plasmid DNA and cellular DNA
give a reliable estimate of copy number (Sambrook et al, 1989), as
described previously (Davies et al, 1994; Oates et al, 1996; Chen
et al, 1997). Equal loading of cellular DNA of the transformant and
parental cell lines was indicated by equal sample intensity on the
gel following electrophoresis and staining with ethidium bromide.
There were no higher molecular weight bands hybridising to the
OPN cDNA probe, indicating that digestion of genomic DNA by
EcoR1 was complete in all cases. Osteopontin and S100A4 mRNA
levels were normalised for differences in loading/transfer by
dividing the intensity of the cDNA hybridised band by the
intensity of the ethidium bromide-stained 28S ribosomal RNA
band, rather than the intensity of an actin cDNA-hybridised band
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DNA.
Statistical analysis
The Student’s t-test and linear regression analysis to determine
correlation coefficients were carried out using the Microsoft
EXCEL package. The significance of the latter fit to a straight line
was calculated, P values of less than 0.05 were considered
statistically significant.
RESULTS
Metastatic potential of clonal cell lines
Nine clonal cell lines were established from the original pool of
Rama 37 cells transfected with C9-Met-DNA, they were termed
R37C9VM followed by clone numbers. Within the set of clonal cell
lines, various cellular morphologies were observed, ranging from
tightly clustered cuboidal to a more elongated morphology
(Table 1). Eight of the nine clonal cell lines produced primary
tumours in all animals. The exception was the cell line R37C9VM6
which failed to produce primary tumours in any animals. Of the
cell lines that produced primary tumours, lung metastases were
detected in 32–71% of the tumour-bearing animals (Table 1). This
range compares with the 24% lung metastases reported for the
pool of Rama 37 cells transfected with C9-Met-DNA and with no
metastases from the Rama 37 cell line (Oates et al, 1996; Chen et al,
1997) There was no correlation between cellular morphology and
percent metastasis (Table 1).
Osteopontin and S100A4 mRNA levels
Northern blotting showed that six of the nine clonal cell lines had
significantly higher levels of the correct size, 1.6kb, osteopontin
mRNA than the Rama 37 cell line, with the increase in levels
ranging from 2.8- to 11.1-fold (Student’s t-test, Pp0.046) (Table 2)
(Figure 1A, C). Osteopontin mRNA levels were corrected for
differences in loading/transfer by normalisation to the 28S
ribosomal RNA (Materials and Methods). The remaining three
cell lines R37C9VM6, R37C9VM8 and R37C9VM29 failed to exhibit
significantly elevated levels compared with the Rama 37 cell line.
Furthermore, with the exception of R37C9VM18, all the clonal cell
lines were shown to be significantly different from the C9-Met-
DNA transfectant pool of Rama 37 cells (Po0.05) (Table 2). When
the metastatic potential in vivo and the relative osteopontin mRNA
levels in the cultured cell lines were plotted against each other,
there was a significant linear relationship between them (linear
regression analysis: R
2¼0.74, P¼0.0007) (Figure 1D). The mRNA
levels of another metastasis-inducing gene in this system, S100A4,
failed to show significant differences for either the clonal cell lines
or the pooled transfectants in comparison with that of the Rama 37
cell line (P40.05) (Table 2) (Figure 1B, C). Furthermore, when the
metastatic potential of the cell lines in vivo was plotted against
S100A4 mRNA levels, there was no simple linear relationship
between the two variables (linear regression analysis: R
2¼0.21,
P¼0.16) (Figure 1E). There was also no correlation between the
levels of osteopontin mRNA and S100A4 mRNA (Table 3). The
control cell line from a transplantable metastatic tumour, Rama
800 expressed both mRNAs at the correct size (Figure 1A, B).
C9-Met-DNA copy number
The number of copies of C9-Met-DNA integrated into the genome
of each of the cell lines was assessed by Southern blotting. Six of
the clonal cell lines from the C9-Met-DNA transfectants possessed
approximately 80–170 copies of C9-Met-DNA fragments per
haploid genome (R37C9VM3, R37C9VM8, R37C9VM13,
R37C9VM14, R37C9VM18 and R37C9VM25) (Table 2)
(Figure 2A). The remaining clonal cell lines possessed much lower
C9-Met-DNA copy numbers of 0–10 (Table 2) (Figure 2A). Seven
of the nine clonal cell lines had significantly higher numbers of C9-
Table 1 Morphology in culture and incidence of tumours and metastases in vivo of C9-Met-DNA transfectants
Cell line Morphology in culture No. of rats
No. of tumour
bearing rats
a
No. of tumour bearing
rats with metastases
b
Percent
metastasis
c
R37 Cuboidal 20
d 16
d 0
d 0
d
R37C9VM3 Cuboidal with pseudopodia 21 21 15
e 71
e
R37C9VM6 Cuboidal, tightly clustered 20 0 0 0
R37C9VM8 Pseudocuboidal
f 22 22 7
e 32
e
R37C9VM13 Pseudocuboidal
f 21 21 11
e 52
e
R37C9VM14 Pseudocuboidal
f with
pseudopodia
18 18 12
e 67
e
R37C9VM16 Cuboidal, tightly clustered 20 20 8
e 40
e
R37C9VM18 Elongated with pseudopodia 18 18 8
e 44
e
R37C9VM25 Elongated 21 21 13
e 62
e
R37C9VM29 Cuboidal, very tightly clustered. 18 18 6
e 33
e
R37C9Pooled Mixed 21
d 21
d 5
e 24
e
aAssayed after 3 months.
bDetermined histologically.
cNo.of tumour-bearing rats with metastases/no. of tumour-bearing rats 100.
dData from Chen et al (1997).
eSignificantly
greater than Rama 37 (Po0.05; Fisher’s exact test).
fApparently cuboidal in morphology caused by over- and underlapping of elongated cellular processes (Warburton et al,
1981; Rudland et al, 1989).
Table 2 Relative levels of osteopontin and S100A4 mRNA and C9-Met-
DNA copy number in the C9-Met-DNA transfectants
Cell line OPN
a mRNAS100A4
a mRNAC9-Met-DNA copy number
b
R37 1
c (70.13) 1 (70.23) 0
R37C9 VM3 11.1 (70.55)
c,d 1.6 (70.15) 147 (717)
c,d
R37 C9 VM6 0.5 (70.18)
c 0.8 (70.47) 0
R37 C9 VM8 1.4 (70.14)
c 1.2 (70.19) 169 (78)
c,d
R37 C9 VM13 5.5 (70.20)
c,d 1.6 (70.16) 133 (710)
c,d
R37 C9 VM14 8.0 (70.5)
c,d 0.6 (70.38) 95 (76)
d
R37 C9 VM16 2.8 (70.16)
c,d 1.5 (70.15) 8 (73)
d
R37 C9 VM18 4.5 (70.24)
d 0.8 (70.05) 83 (75)
d
R37 C9 VM25 9.3 (71.1)
c,d 2.2 (70.43) 145 (717)
c,d
R37 C9 VM29 0.7 (70.21)
c 1.3 (70.34) 3 (70.3)
R37 C9Pooled 4.3 (70.28)
d 0.8 (70.14) 50
d,e
aRelative mRNA levels determined by Northern blotting.
bC9-Met-DNA copy
number determined by Southern blotting.
cSignificantly different from C9-Met-DNA
pooled transfectants (Po0.05; Student’s t-test).
dSignificantly different from Rama 37
(Po0.05; Student’s t-test).
eData from Chen et al (1997). Values in brackets represent
the mean7standard deviation of three separate experiments.
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Po0.05) (Table 2). The remaining two cell lines R37VM6 and
R37C9VM29 did not have significantly higher levels. Moreover, the
clonal cell lines R37C9VM3, VM8, VM13 and VM25 possessed
significantly different levels of C9-Met-DNA compared to the C9-
Met-DNA transfectant pool of Rama 37 cells (Student’s t-test;
Po0.05) (Table 2). When the number of integrated copies of C9-
Met-DNA was plotted against the metastatic potential, there was a
moderate but significant correlation (linear regression analysis:
R
2¼0.48, P¼0.02) (Figure 2B) (Table 3). There was also a
moderate but significant correlation between the C9-Met-DNA
copy number and the level of OPN mRNA (linear regression
analysis: R
2¼0.43, P¼0.03) but not with levels of S100A4 mRNA
(linear regression analysis: R
2¼0.16, P¼0.22) (Table 3).
Growth rates
Growth curves were constructed for each cell line in order to
determine their average growth rate. All the cell lines that had been
transfected previously with C9-Met-DNA showed a statistically
significant reduction in growth rate over that obtained for the
untransfected Rama 37 cells (Student’s t-test; Po0.012). When the
relative growth rates were plotted against their metastatic
potential, there was no statistically significant correlation between
the two variables (linear regression analysis: R
2¼0.2, P¼0.17)
(Table 3). There was also no correlation of growth rate with levels
of osteopontin mRNA (R
2¼0.03, P¼0.63) or of S100A4 mRNA
(R
2¼0.01, P¼0.76) (Table 3).
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Figure 1 An example of a Northern blot for OPN and S100A4 mRNA
levels in the clonal cell lines. The following samples were electrophoresed
through 0.8% (wv
 1) formaldehyde agarose gels and blotted onto
Hybond-N membrane: Rama 800 (lane 1), R37C9Pooled (lane 2),
R37C9VM13 (lane 3), R37C9VM16 (lane 4), R37C9VM8 (lane 5),
R37C9VM6 (lane 6), R37C9VM25 (lane 7), Rama 37 (lane 8),
R37C9VM29 (lane 9), R37C9VM14 (lane 10), R37C9VM3 (lane 11),
R37C9VM18 (lane 12). In panel (A) the membrane was incubated with
a
32P-labelled OPN cDNA and subjected to autoradiography. In panel (B)
the membrane was incubated with a
32P-labelled S100A4 cDNA and
subjected to autoradiography. In panel (C) the ethidium bromide-stained
18S and 28S ribosomal RNA bands on the membrane before hybridisation
were photographed. The 1.6kb OPN mRNA, 0.8kb S100A4 mRNA and
18S and 28S ribosomal RNAs are shown. (D) Graph of OPN mRNA levels
of the cloned cell lines in culture relative to that in Rama 37 cells (Relative
OPN mRNA level) plotted against their metastatic potential in vivo (%
Metastasis) (Materials and Methods). (E) S100A4 mRNA levels of the
cloned cell lines in culture relative to that in Rama 37 cells (Relative S100A4
mRNA level) plotted against their metastatic potential in vivo (% Metastasis)
(Materials and Methods). (D,E) Contain results for 9 C9-Met-DNA-
transfected Rama 37 cell lines plus the uncloned C9-Met-DNA-transfected
cells and the parental Rama 37 cells.
Table 3 Pairwise comparison of the cellular and molecular characteristics
of transfectants
Pairwise comparison
a R
2,b P
c
OPN mRNA level/plating efficiency 0.91 5.9 10
 6d
OPN mRNA level/growth potential 0.03 0.63
OPN mRNA level/C9-Met-DNA copy no. 0.43 0.03
d
OPN mRNA level/metastatic potential 0.74 0.0007
d
OPN mRNA level/S100A4 mRNA level 0.16 0.23
S100A4 mRNA level/plating efficiency 0.21 0.16
S100A4 mRNA level/growth potential 0.01 0.76
S100A4 mRNA level/metastatic potential 0.21 0.16
S100A4 mRNA level/C9-Met-DNA copy no. 0.16 0.22
C9-Met-DNA copy no./metastatic potential 0.48 0.02
d
Plating efficiency/metastatic potential 0.73 0.0008
d
Growth potential/metastatic potential 0.2 0.17
aNo. of cell lines tested by linear regression analysis is 11: nine clonal cell lines of the
C9-Met-DNA-transfected cells plus the uncloned C9-Met-DNA-transfected Rama
37 cells and the parental Rama 37 cells.
bLinear regression coefficient (R
2).
cProbability
(P) that population lies on a straight line.
dSignificant at a 5% level.
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Figure 2 An example of Southern hybridisation of C9-Met-DNA to
DNA obtained from the clonal cell lines. (A) DNA from each of the cell
lines was digested with EcoR1, electrophoresed on agarose gels, and
blotted onto Hybond-N membrane. The samples loaded on the gel were
500 copies C9-Met-DNA (lane 1), 50 copies C9-Met-DNA (lane 2), Rama
37 DNA (lane 3), R37C9VM18 (lane 4), R37C9VM13 (lane 5), R37C9VM6
(lane 6), R37C9VM29 (lane 7), R37C9VM14 (lane 8), R37C9VM3 (lane 9),
R37C9VM8 (lane 10), R37C9VM16 (lane 11) and R37C9VM25 (lane 12).
The membrane was incubated with a
32P-labelled C9-Met-DNA under
hybridising conditions and subjected to autoradiography. The position of
the authentic C9-Met-DNA is shown by the arrow. (B) Graph of C9-Met-
DNA copy number (copy no) of the cell lines plotted against their
metastatic potential in vivo (% Metastasis) (Materials and Methods). Results
for the nine cloned C9-Met-DNA-transfected cell lines plus Rama 37
parental cells are shown.
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Adhesive potential of the C9-Met-DNA transfectants was deter-
mined from their plating efficiency over a 15-min period in
conditioned medium exposed for 3 days to the growing
transfectants (Materials and Methods). Seven of the nine C9-
Met-DNA transfectants possessed a statistically increased plating
efficiency over that of the untransfected Rama 37 cells (Student’s t-
test; Po0.002) (Figure 3A). The remaining two cell lines,
R37C9VM6 and R37C9VM29 failed to show a significant increase.
When the plating efficiency was plotted against the metastatic
potential, there was a statistically significant linear correlation
between these two variables (linear regression analysis: R
2¼0.73,
P¼0.0008) (Figure 3B) (Table 3). There was also a highly
significant correlation of adhesive potential with levels of OPN
mRNA (R
2¼0.91, P¼6 10
 6), but not with levels of S100A4
mRNA (R
2¼0.21, P¼0.16) (Table 3). To test whether the
conditioned medium or the cells were causing the increase in
adhesiveness of the OPN-expressing transfectants, all the transfec-
tants were retested for adhesive potential in fresh routine medium
not exposed to cells. There was no significant difference in plating
efficiency for any of the transformant or parental cell lines when
tested in routine or conditioned media (Students’ t-test, P40.05).
Furthermore, under these conditions, there was also a statistically
significant linear correlation between plating efficiency and
metastatic potential (linear regression analysis, R
2¼0.78,
P¼0.00031), and plating efficiency and levels of OPN mRNA
(R
2¼0.93, P¼2 10
 6) (not shown); the levels of correlation were
similar to those observed earlier when transformant and parental
cell lines were tested in their conditioned media rather than in
fresh, unconditioned media.
DISCUSSION
To assess the association of levels of osteopontin mRNA
with metastasis and other molecular and cellular characteristics,
a series of single-cell-cloned cell lines has been isolated from
the original pool of C9-Met-DNA Rama 37 transfectants described
by Chen et al (1997). That the C9-Met-DNA-transfected clonal
cell lines possess a range of morphologies in culture and show
different metastatic potentials in vivo suggests that the pool of
C9-Met-DNA-transfected Rama 37 cells is a mixed population
of cell types. This suggestion may explain why a linear correlation
between the osteopontin mRNA levels and metastatic potential of
the various pooled transfectants produced from the other Met-
DNAs (C6-Met-DNA, etc.), although significantly increased, was
not observed (Chen et al, 1997). For example, the Rama 37 cells
transfected with C6-Met-DNA induced a relatively high level of
metastasis (50%), but the increase in osteopontin mRNA was
relatively modest (1.6-fold), whereas Rama 37 cells transfected
with C9-Met-DNA induced a lower level of metastasis (23%), but
showed a relatively high increase in osteopontin mRNA (4.4-fold).
Previously, osteopontin mRNA levels have been suggested to be
the effector of all the Met-DNA fragments, including C9-Met-DNA
in the induction of metastasis (Oates et al, 1996; Chen et al, 1997).
Furthermore, the levels of osteopontin mRNA have been shown to
reflect the levels of osteopontin protein in Met-DNA-transfected
Rama 37 cells (Oates et al, 1996; Chen et al, 1997; El-Tanani et al,
2001). Now the dose-dependent relationship observed between
osteopontin mRNA levels in culture and metastatic potential in
vivo for the clonal cell lines provides strong evidence that, in the
case of these C9-Met-DNA-transfected clonal cell lines, metastatic
potential in vivo is linearly correlated with the osteopontin mRNA
levels found in the cultured cells. Hence, it is highly probable that
increases in the relative amounts of osteopontin protein produced
by the tumour cells is the final effector of at least C9-Met-DNA.
Moreover, another gene known to induce metastasis in Rama 37
cells, that for S100A4 (Davies et al, 1993), does not have
significantly higher levels of mRNA in the C9-Met-DNA clonal
cell lines than in the untransfected Rama 37 cell line. Thus, it is
highly likely that increased osteopontin mRNA levels (and hence
protein) are the direct cause of the elevated metastatic potential in
the C9-Met-DNA-transfected Rama 37 cells. This conclusion is
substantiated by experiments that show overexpression of
osteopontin by stable transfection of an expression vector in
Rama 37 cells induces a metastatic phenotype (Oates et al, 1996).
Furthermore, the association of osteopontin overexpression both
with tumour progression and with metastasis has been documen-
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Figure 3 (A) Adhesive potential of the transfectant cell lines and the
pool of Rama 37 cells transfected with C9-Met-DNA. Plating efficiency
defined as percentage of cells attached to plastic substratum after 15min
incubation in self-conditioned medium at 371C is shown for the parental
Rama 37 (R37), the C9-Met-DNA-transfected cell lines (R37C9VM3 etc)
and the C9-Met-DNA pooled transfectants (R37C9Pooled). * Statistically
different plating efficiency from the Rama 37 cell line (Po0.05; Student’s t-
test). (B) Graph of the mean plating efficiency of the cell lines plotted
against their metastatic potential in vivo (% Metastasis) (Materials and
Methods).
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1994; Feng et al, 1995; Behrend et al, 1995) and in human studies
(Singh et al, 1997; Tuck et al, 1997; Rudland et al, 2002).
Both the loss and gain of cell–cell adhesion is important for
metastasis. For example, in the early stages of metastasis, the cell
adhesion molecule E-cadherin is often lost, allowing cells to escape
from the primary tumour (Christofori and Semb, 1999). However,
at more advanced stages of malignancy, E-cadherin appears to be
re-expressed (Bukholm et al, 2000). In this report, osteopontin
mRNA levels are linearly correlated with cellular adhesive potential
in this set of clonal C9-Met-DNA-transfected Rama 37 cell lines.
This result suggests that the mechanism by which the increased
osteopontin levels cause increased metastatic potential in these
cells is by increasing cellular adhesiveness, at least in part,
although other mechanisms cannot be excluded. Since there was
no difference in the plating efficiency when transformant and
parental cell lines were tested in their conditioned or fresh
unconditioned media, the increase in adhesiveness of the
transfectants arises almost exclusively from the cells themselves
and not from material secreted into the conditioned medium.
Increases in cellular adhesion could allow attachment of the
tumour cells to vessel walls before extravasation and migration to
their chosen site of metastasis. This hypothesis is supported by the
evidence that osteopontin has also been shown to mediate cellular
adhesion of several different types of cells including human breast
cancer cells, transformed NIH 3T3 cells and erythroleukaemic cells
(Liaw et al 1994; Barry et al, 2000).
During the process of metastasis, intercellular contact mediated
through the cell adhesion molecule E-cadherin appears to prevent
apoptosis (Kantak and Kramer, 1998; Day et al, 1999). There is
growing evidence to suggest that osteopontin may also inhibit
apoptosis during metastasis. The inhibition of apoptosis by OPN
has been shown in a variety of cell types including human breast
cancer cells and endothelial cells (Lopez et al, 1996; Khan et al,
2002). Additionally, osteopontin-deficient vascular smooth muscle
cells show increased apoptosis and decreased adherence. This not
only provides further evidence for the role of osteopontin in
cellular adherence but also in the inhibition of apoptosis
(Weintraub et al, 2000). The mechanism by which osteopontin
inhibits apoptosis is thought to be via multiple ligand receptor
interactions in response to various proapoptotic signals (Denhardt
et al, 2001). Therefore, osteopontin-mediated adhesion of the
tumour cells could be operating in the same manner as re-
expressed E-cadherin. Initially apoptosis is inhibited, allowing the
tumour cells in the circulation to survive and then through
increasing cell–cell adhesion, the tumour cells become attached to
blood vessel walls ready for extravasation.
Other properties that can be affected by an increase in
osteopontin expression include an increase in matrix metallopro-
teinase expression (Teti et al, 1998), an increase in cellular
migration (Liaw et al, 1994; Tuck et al, 2000) and a protective
capacity of tumour cells from macrophage-mediated nitric oxide
attack (Denhardt and Chambers, 1994; Feng et al, 1995). These
potential changes and others have not been assayed in the present
system, and it is possible that all, or a combination of properties,
not just increased cellular adhesion are responsible for the cell
lines with high levels of osteopontin mRNA becoming metastatic
in vivo. However, the results clearly demonstrate that the C9-Met-
DNA-transfected cells have not simply gained a selective growth
advantage over untransfected Rama 37 cells, since the growth rates
of the clonal cell lines in vitro do not correlate separately with
either metastatic potential or osteopontin mRNA levels. Moreover,
the benign untransfected Rama 37 cell line possesses a significantly
faster growth rate in vitro than the majority of the clonal cell lines
and the latent period before the tumours appear in vivo is similar
in the parental Rama 37 cell line and in the C9-Met-DNA-
transfected clonal cell lines, both results mitigating against growth
advantage being the cause of metastasis in this system.
That there is only a moderately significant linear relationship
between metastatic potential and C9-Met-DNA copy number
suggests that, although the presence of C9-Met-DNA is essential,
it may not necessarily be sufficient for the transfected Rama 37 cell
to become metastatic in vivo. Digestion of genomic DNA by EcoR1
was complete in all cases, as described in Materials and Methods,
so eliminating the possibility of anomalous numbers of integrated
copies of transfected OPN cDNA being recorded. C9-Met-DNA has
been postulated to act by the removal of the transcription factor
Tcf-4 from the osteopontin promoter, where it acts normally to
suppress osteopontin transcription (El-Tanani et al, 2001). For
Tcf-4 to be removed from the osteopontin promoter by the C9-
Met-DNA, the integrated copies of C9-Met-DNA in the chromatin
need to be in a conformation that is accessible to proteins, that is
unwound. This state would probably depend on their becoming
integrated into a region of the genome of a Rama 37 cell that is
actively transcribed. Different sites of integration of the con-
catamers of C9-Met-DNA (Chen et al, 1997) could explain the
observation in this report that occasionally large numbers of
integrated C9-Met-DNA fragments occur in transfected cells with
low levels of osteopontin mRNA and a low metastatic potential
(e.g. R37C9VM8).
To conclude, this report proves that the original pool of C9-Met-
DNA-transfected Rama 37 cells is a mixed population of cells with
various molecular and cellular characteristics. Moreover, the close
association between osteopontin mRNA levels and metastatic
potential of the C9-Met-DNA clonal cell lines provides further
evidence that the direct effect of C9-Met-DNA is indeed mediated
through the increase in osteopontin mRNA levels. Finally the
pairwise linear correlations between metastatic potential, and both
osteopontin mRNA levels and plating efficiency of the cells
suggests that the mechanism by which osteopontin increases
metastatic potential is mediated, at least in part, by increasing the
adhesion of the tumour cells in this system.
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